ArticleAddiction science & clinical practice2023

Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study.

Maximilian Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.